A Framework for Developing Pharmacotherapy for Agitation in Alzheimer’s disease: Recommendations of the ISCTM Working Group

ISCTM: International Society for CNS Clinical Trials and Methodology

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish (US)
Pages (from-to)274-282
Number of pages9
JournalThe journal of prevention of Alzheimer's disease
Issue number4
StatePublished - Aug 1 2020

ASJC Scopus subject areas

  • Medicine(all)

Cite this